The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility

Abstract The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shing Cheng Tan, Teck Yew Low, Ezanee Azlina Mohamad Hanif, Mohamad Ayub Khan Sharzehan, Hamed Kord-Varkaneh, Md Asiful Islam
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/19da81a27c5a4b1188960db30747bbc6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:19da81a27c5a4b1188960db30747bbc6
record_format dspace
spelling oai:doaj.org-article:19da81a27c5a4b1188960db30747bbc62021-12-02T17:26:55ZThe rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility10.1038/s41598-021-97935-82045-2322https://doaj.org/article/19da81a27c5a4b1188960db30747bbc62021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97935-8https://doaj.org/toc/2045-2322Abstract The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887–1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861–1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875–1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908–1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919–1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.Shing Cheng TanTeck Yew LowEzanee Azlina Mohamad HanifMohamad Ayub Khan SharzehanHamed Kord-VarkanehMd Asiful IslamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shing Cheng Tan
Teck Yew Low
Ezanee Azlina Mohamad Hanif
Mohamad Ayub Khan Sharzehan
Hamed Kord-Varkaneh
Md Asiful Islam
The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
description Abstract The ESR1 rs9340799 polymorphism has been frequently investigated with regard to its association with breast cancer (BC) susceptibility, but the findings have been inconclusive. In this work, we aimed to address the inconsistencies in study findings by performing a systematic review and meta-analysis. Eligible studies were identified from the Web of Science, PubMed, Scopus, China National Knowledge Infrastructure, VIP and Wanfang databases based on the predefined inclusion and exclusion criteria. The pooled odds ratio (OR) was then calculated under five genetic models: homozygous (GG vs. AA), heterozygous (AG vs. AA), dominant (AG + GG vs. AA), recessive (GG vs. AA + AG) and allele (G vs. A). Combined results from 23 studies involving 34,721 subjects indicated a lack of significant association between the polymorphism and BC susceptibility (homozygous model, OR = 1.045, 95% CI 0.887–1.231, P = 0.601; heterozygous model, OR = 0.941, 95% CI 0.861–1.030, P = 0.186; dominant model, OR = 0.957, 95% CI 0.875–1.045, P = 0.327; recessive model, OR = 1.053, 95% CI 0.908–1.222, P = 0.495; allele model, OR = 0.987, 95% CI 0.919–1.059, P = 0.709). Subgroup analyses by ethnicity, menopausal status and study quality also revealed no statistically significant association (P > 0.05). In conclusion, our results showed that the ESR1 rs9340799 polymorphism was not associated with BC susceptibility, suggesting its limited potential as a genetic marker for BC.
format article
author Shing Cheng Tan
Teck Yew Low
Ezanee Azlina Mohamad Hanif
Mohamad Ayub Khan Sharzehan
Hamed Kord-Varkaneh
Md Asiful Islam
author_facet Shing Cheng Tan
Teck Yew Low
Ezanee Azlina Mohamad Hanif
Mohamad Ayub Khan Sharzehan
Hamed Kord-Varkaneh
Md Asiful Islam
author_sort Shing Cheng Tan
title The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
title_short The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
title_full The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
title_fullStr The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
title_full_unstemmed The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
title_sort rs9340799 polymorphism of the estrogen receptor alpha (esr1) gene and its association with breast cancer susceptibility
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/19da81a27c5a4b1188960db30747bbc6
work_keys_str_mv AT shingchengtan thers9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT teckyewlow thers9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT ezaneeazlinamohamadhanif thers9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT mohamadayubkhansharzehan thers9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT hamedkordvarkaneh thers9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT mdasifulislam thers9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT shingchengtan rs9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT teckyewlow rs9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT ezaneeazlinamohamadhanif rs9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT mohamadayubkhansharzehan rs9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT hamedkordvarkaneh rs9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
AT mdasifulislam rs9340799polymorphismoftheestrogenreceptoralphaesr1geneanditsassociationwithbreastcancersusceptibility
_version_ 1718380776322498560